fashion -WSS

fashion

author：focus 2025-09-30 22:27:51 - browse：2

Committee chairman Rep. Jason Smith (R-MO) speaks with ranking member Rep. Richard Neal (D-MA) during a House Ways and Means Committee hearing on Capitol Hill March 10, 2023 in Washington, DC. – health care policy coverage from STAT — Committee chairman Rep. Jason Smith (R-Mo.) speaks with ranking member Rep. Richard Neal (D-Mass.). Drew Angerer/Getty Images

WASHINGTON — It’s two weeks until Congress leaves town in August, and a prominent House panel is throwing a wrench in what seemed like a smooth path forward for legislation to require more transparency in health care prices, and to change Medicare drug payments.

The House Energy & Commerce Committee already introduced, held multiple hearings on, and unanimously passed out of committee a package of legislation including transparency requirements for hospitals and pharmacy benefit managers and a so-called “site-neutral” pay policy for drugs administered in doctors’ offices.

But leaders of the House Ways & Means Committee are planning to release their own health care legislation this month, complicating the chamber’s path to passing something soon, four lobbyists told STAT.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： WHO may add ‘noma' to its list of neglected tropical diseases

WSS

Physician subsidies by hospitals soar in wake of No Surprises Act

The FDA weighs the risks of candy

My yearlong odyssey to get my son’s ADHD medication covered

Meta's Zuckerberg and Chan on track to put $50 billion into science

FDA clears AI tool for detecting skin cancer

NIH director takes cautious approach to Biden drug pricing priority

explore

fashion

focus

Activists slam private health insurers over coverage restrictions

Senate panel to vote on hospitals, PBMs, prisoner care

How one medical school became remarkably diverse

Prior authorization will have to move faster under new Biden rule

Drug repurposing or repositioning? The language matters

AI generated plenty of interest at JPM but not a lot of trust

State Dept. review finds Biden bears some blame for Afghanistan failures

Diversifying clinical trials isn't enough to close racial gaps: study

Bright Health sells Medicare Advantage business to Molina

FDA has safety concerns on CRISPR

hotspot

Physician subsidies by hospitals soar in wake of No Surprises Act

First Opinion Podcast: How to protect health care in times of war

The surgeon had a dilemma only a Nazi medical text could resolve

Diversifying clinical trials isn't enough to close racial gaps: study

Maker of FluMist seeks to allow at

Maker of FluMist seeks to allow at

hotspot

hotspot

focus

focus